Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Poliglumex and Transdermal Estradiol in Androgen-Independent Prostate Cancer
NCT00459810Phase 2Terminated
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Feb 2007
- Primary completion
- Jul 2009
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel poliglumex in prostate cancer (PCa), sponsored by OHSU Knight Cancer Institute. Started Feb 2007; status: terminated.
02
Drugs
paclitaxel poliglumex
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00459810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00459810.